Medications in Morocco: Insufficient Decrees to Meet WHO Standards
Title: Morocco’s Pharmaceutical Reforms: A Step Forward or Just a Facade?
Presented as a significant advancement in the reform of the pharmaceutical sector, three new decrees on medications in Morocco are struggling to gain traction and acceptance. Behind the regulatory facade, numerous voices are rising to denounce what they perceive as an incomplete reform, far from the standards set by the World Health Organization (WHO).
On paper, these new regulations aim to regulate medication prices, enhance transparency, and modernize authorization procedures. However, in practice, they seem more like technical adjustments rather than a genuine overhaul of Morocco’s pharmaceutical system. It is precisely this deep transformation that international standards require.
The main point of contention lies in the governance of the sector. The absence of a strong, independent authority capable of effectively regulating the pharmaceutical market remains a significant concern. Additionally, the lack of transparency in price-setting has been consistently criticized by industry professionals and observers alike.
As a result, the prices of medications in Morocco remain high for many treatments, limiting access to healthcare for a segment of the population. This situation stands in stark contrast to the WHO’s guidance, which advocates for equitable and widespread access to essential medicines.
Another major shortcoming is the still insufficient development of generic and biosimilar drugs. These alternatives are crucial for reducing costs and improving accessibility. Yet, the new decrees do not appear to establish the necessary incentives to sustainably transform the market.
Amidst this backdrop, the question of Morocco’s pharmaceutical sovereignty remains unresolved. The reliance on imports, combined with limited local production, weakens the system in the face of international crises and supply chain tensions.
In this context, the recently adopted decrees seem to provide only a partial response to structural challenges. To align with WHO standards, Morocco must go beyond these measures and embark on a more ambitious reform focused on transparency, independent regulation, and equitable access to medicines.
Ultimately, beyond the regulations, it is the credibility and effectiveness of the healthcare system that is at stake.
